28th Jul 2009 11:10
28 July 2009
GW Pharmaceuticals plc("GW" or "the Company")
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
The company has today been notified that on 27 July 2009 Dr Geoffrey Guy, a Director of the Company, sold 750,000 ordinary shares of 0.1p to Dr Brian Whittle for consideration of 79 pence per share. Dr Whittle co-founded the Company with Dr Guy and was a Director of the Company until his retirement in 2008.
In addition, Dr Guy also gifted, for nil consideration, a further 782,111 ordinary shares of 0.1p to Dr Whittle and members of Dr Whittle's family.
The total transfer of 1,532,111 shares amounts to 1.27% of the issued ordinary share capital.
Following this notification Dr Guy retains a beneficial interest in 18,323,952 ordinary shares, amounting to 15.17% of the shares in issue.
Enquiries:
GW Pharmaceuticals plc 01980 557000
Adam George, Company Secretary
Nominated Adviser 0207 597 5970
Patrick Robb, Investec Bank plc
Related Shares:
GWP.L